BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-25 out of 71 found
  Current Search:  zelnorm: 71     

HTML
100%
Callisto Pharmaceuticals Announces $3.0 Million Financing by Its Synergy Pharmaceuticals Subsidiary and Relate
NEW YORK--(BUSINESS WIRE)--Callisto Pharmaceuticals, Inc.

(Pink Sheets: CLSP; FWB: CA4), announced today that its Synergy Pharmaceuticals, Inc.

closed a $3.0 million private placement.

The proceeds of the private placement will be used...

Business Wire via Yahoo!:  Jul 21 2008 4:35PM
Matching: zelnorm
Find similar documents
HTML
100%
Pawfect Foods Announces Acquisition of Synergy Pharmaceuticals and $3.0 Million Financing
Pawfect Foods, Inc., a Florida corporation (PWFF.OB) announced today that it acquired Synergy Pharmaceuticals, Inc.

in exchange for shares of its common stock issued to Callisto Pharmaceuticals, Inc.

(CLSP; FWB: CA4) and completed a $3.0...

Houston Chronicle:  Jul 21 2008 4:08PM
Matching: zelnorm
Find similar documents
HTML
100%
Callisto Pharmaceuticals Announces $3.0 Million Financing by Its Synergy Pharmaceuticals Subsidiary and Relate
Callisto Pharmaceuticals, Inc.

(CLSP; FWB: CA4), announced today that its Synergy Pharmaceuticals, Inc.

closed a $3.0 million private placement.

The proceeds of the private placement will be used to fund the development of SP-304, its...

Houston Chronicle:  Jul 21 2008 4:07PM
Matching: zelnorm
Find similar documents
HTML
100%
Callisto Pharmaceuticals Announces $3.0 Million Financing by Its Synergy Pharmaceuticals Subsidiary and Relate
Author : NY-CALLISTO Category : Press Release News Alerts by Email click here ) News | Home NEW YORK - (Business Wire) Callisto Pharmaceuticals, Inc.

(Pink Sheets: CLSP; FWB: CA4), announced today that its Synergy Pharmaceuticals, Inc.

Earthtimes.org:  Jul 21 2008 3:54PM
Matching: zelnorm
Find similar documents
HTML
100%
Pawfect Foods Announces Acquisition of Synergy Pharmaceuticals and $3.0 Million Financing
Author : NY-PAWFECT-FOODS Category : Press Release News Alerts by Email click here ) News | Home NEW YORK - (Business Wire) Pawfect Foods, Inc., a Florida corporation (PWFF.OB) announced today that it acquired Synergy Pharmaceuticals, Inc.
Earthtimes.org:  Jul 21 2008 3:46PM
Matching: zelnorm
Find similar documents
HTML
100%
Pawfect Foods Announces Acquisition of Synergy Pharmaceuticals and $3.0 Million Financing
NEW YORK--(BUSINESS WIRE)--Pawfect Foods, Inc., a Florida corporation (PWFF.OB) announced today that it acquired Synergy Pharmaceuticals, Inc.

in exchange for shares of its common stock issued to Callisto Pharmaceuticals, Inc.

(Pink...

Business Wire via Yahoo!:  Jul 21 2008 3:33PM
Matching: zelnorm
Find similar documents
HTML
100%
Pawfect Foods Announces Acquisition of Synergy Pharmaceuticals
Callisto Pharmaceuticals Inc (CLSP) Stock Quote, Chart, News, Add to Watchlist Pawfect Foods, Inc., a Florida corporation (PWFF.OB) announced today that it acquired Synergy Pharmaceuticals, Inc.

in exchange for shares of its common stock...

Business Wire via MSN Money:  Jul 21 2008 3:31PM
Matching: zelnorm
Find similar documents
HTML
100%
Novartis posts 17 percent rise in 2Q net income
BASEL, Switzerland (AP) - Drug maker Novartis AG on Thursday reported a 17 percent increase in net income for the second quarter, thanks to recent acquisitions and strong sales.

Net income rose to $2.3 billion in the three months ending...

Find Law:  Jul 19 2008 8:17AM
Matching: zelnorm
Find similar documents
HTML
100%
Novartis A Swiss Treat For Investors
Novartis was a tasty Swiss treat for investors on Thursday after the pharma company posted strong earnings despite a slew of pressures.

A weak dollar and a savings program mean good bucks for drug maker Novartis.

The Swiss firm posted an...

Forbes.com:  Jul 17 2008 11:32PM
Matching: zelnorm
Find similar documents
HTML
100%
PRESS RELEASE Novartis Gains Momentum With -2- (DJ)
healthcare.

Net sales from continuing operations for the Group are expected to rise at a mid-single-digit rate, and at a low-single-digit growth rate in the Pharmaceuticals Division, both in local currencies.

Sandoz is now expected to...

Easy Bourse:  Jul 17 2008 7:05AM
Matching: zelnorm
Find similar documents
HTML
100%
Novartis posts 17 percent rise in 2Q net income
BASEL, Switzerland Drug maker Novartis AG on Thursday reported a 17 percent increase in net income for the second quarter, thanks to recent acquisitions and strong sales.

Net income rose to $2.3 billion in the three months ending June 30,...

South Carolina Enquirer-Herald:  Jul 17 2008 7:03PM
Matching: zelnorm
Find similar documents
HTML
100%
Novartis posts 17 percent rise in 2Q net income
BASEL, Switzerland --Drug maker Novartis AG on Thursday reported a 17 percent increase in net income for the second quarter, thanks to recent acquisitions and strong sales.

Net income rose to $2.3 billion in the three months ending June 30...

Macon Telegraph:  Jul 17 2008 6:26PM
Matching: zelnorm
Find similar documents
HTML
100%
Novartis posts 17 percent rise in 2nd-quarter net income
BASEL, Switzerland-Drug maker Novartis AG on Thursday reported a 17 percent increase in net income for the second quarter, thanks to recent acquisitions and strong sales.

Net income rose to US$2.3 billion (1.45 billion) in the three months...

Macro World Investor:  Jul 17 2008 6:05PM
Matching: zelnorm
Find similar documents
HTML
100%
Novartis Posts 17 Percent Rise in 2Q Net Income
Drug maker Novartis AG on Thursday reported a 17 percent increase in net income for the second quarter, thanks to recent acquisitions and strong sales.

Net income rose to $2.3 billion in the three months ending June 30, from $1.9 billion...

ABC News:  Jul 17 2008 4:58PM
Matching: zelnorm
Find similar documents
HTML
100%
Novartis posts 17 percent rise in 2nd-quarter net income
BASEL, Switzerland-Drug maker Novartis AG on Thursday reported a 17 percent increase in net income for the second quarter, thanks to recent acquisitions and strong sales.

Net income rose to US$2.3 billion (1.45 billion) in the three months...

Calibre Macro World:  Jul 17 2008 4:55PM
Matching: zelnorm
Find similar documents
HTML
100%
Novartis posts 17 percent rise in 2nd-quarter net income, on acquisitions, strong sales
BASEL, Switzerland (AP) - Drug maker Novartis AG on Thursday reported a 17 percent increase in net income for the second quarter, thanks to recent acquisitions and strong sales.

Net income rose to $2.3 billion in the three months ending...

Canadian Business Magazine:  Jul 17 2008 4:17PM
Matching: zelnorm
Find similar documents
HTML
100%
Novartis posts 17 percent rise in 2Q net income
Drug maker Novartis AG on Thursday reported a 17 percent increase in net income for the second quarter, thanks to recent acquisitions and strong sales.

BASEL, Switzerland Drug maker Novartis AG on Thursday reported a 17 percent increase in...

Seattle Times:  Jul 17 2008 3:42PM
Matching: zelnorm
Find similar documents
HTML
100%
Financial Report: Novartis 2Q
2Q Earnings: $2.3 billion (+17%) YTD Revenues: $20.6 billion (+11%) YTD Earnings: $4.6 billion (+13%) Comments: Pharmaceutical sales were $6.9 billion (+14%) in the quarter and $13.2 billion (+10%) in 1H08, driven by Diovan sales along with...
Contract Pharma:  Jul 17 2008 3:24PM
Matching: zelnorm
Find similar documents
HTML
100%
Novartis posts 17 percent rise in 2Q net income
BASEL, Switzerland (AP) - Drug maker Novartis AG on Thursday reported a 17 percent increase in net income for the second quarter, thanks to recent acquisitions and strong sales.

Net income rose to $2.3 billion in the three months ending...

NOLA Live:  Jul 17 2008 3:12PM
Matching: zelnorm
Find similar documents
HTML
100%
Novartis posts 17 percent rise in 2Q net income
BASEL, Switzerland Drug maker Novartis AG on Thursday reported a 17 percent increase in net income for the second quarter, thanks to recent acquisitions and strong sales.

Net income rose to $2.3 billion in the three months ending June 30,...

Savannah Morning News:  Jul 17 2008 2:21PM
Matching: zelnorm
Find similar documents
HTML
100%
Novartis posts 17 percent rise in 2Q net income
BASEL, Switzerland - Drug maker Novartis AG on Thursday reported a 17 percent increase in net income for the second quarter, thanks to recent acquisitions and strong sales.Net income rose to $2.3 billion in the three months ending June 30,...
Post Star:  Jul 17 2008 2:17PM
Matching: zelnorm
Find similar documents
HTML
100%
Novartis posts 17 percent rise in 2Q net income
Drug maker Novartis AG on Thursday reported a 17 percent increase in net income for the second quarter, thanks to recent acquisitions and strong sales.

Net income rose to $2.3 billion in the three months ending June 30, from $1.9 billion...

The Conservative Voice:  Jul 17 2008 2:04PM
Matching: zelnorm
Find similar documents
HTML
100%
Novartis posts 17 percent rise in 2Q net income
BASEL, Switzerland Drug maker Novartis AG on Thursday reported a 17 percent increase in net income for the second quarter, thanks to recent acquisitions and strong sales.</p><p>Net income rose to $2.3 billion in...
Lake Wylie Pilot:  Jul 17 2008 1:18PM
Matching: zelnorm
Find similar documents
HTML
100%
Novartis posts 17 percent rise in 2nd-quarter net income, on acquisitions, strong sales
BASEL, Switzerland (AP) _ Drug maker Novartis AG on Thursday reported a 17 percent increase in net income for the second quarter, thanks to recent acquisitions and strong sales.Net income rose to $2.3 billion in the three months ending June...
Chicago Tribune:  Jul 17 2008 1:11PM
Matching: zelnorm
Find similar documents
HTML
100%
Novartis posts 17 percent rise in 2Q net income
Drug maker Novartis AG on Thursday reported a 17 percent increase in net income for the second quarter, thanks to recent acquisitions and strong sales.

Net income rose to $2.3 billion in the three months ending June 30, from $1.9 billion...

The Baytown Sun:  Jul 17 2008 12:47PM
Matching: zelnorm
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.